Cholestasis

Linerixibat Long-term Safety, and Tolerability Study

Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease

Congenital Heart Diseases and Developmental Assessment in Cholestatic Infants Under Two Years

SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury

Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus

PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy Individuals

PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.

FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)

Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis

Investigation of the Pruritogens of Liver-related Diseases

Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis

Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic Acid

Mallampati Score for Prediction and Prognosis of Postoperative Mortality and Morbidity and Safety Profiles of Patients Undergoing Laparoscopic Cholecystectomy in Qassim Region

FGF19 in Obstructive Cholestasis: "Unveil the Signal"

Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid Therapy

Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in Infants

Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis

Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis

Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD